These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33257110)

  • 1. Re. "Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol." Author response.
    Caccialanza R; Lobascio F; Masi S; Crotti S; Cereda E
    Nutrition; 2021 Jun; 86():111050. PubMed ID: 33257110
    [No Abstract]   [Full Text] [Related]  

  • 2. Re. "Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol".
    Piquet MA; Dupont B
    Nutrition; 2021 Jun; 86():110899. PubMed ID: 32739226
    [No Abstract]   [Full Text] [Related]  

  • 3. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol.
    Caccialanza R; Laviano A; Lobascio F; Montagna E; Bruno R; Ludovisi S; Corsico AG; Di Sabatino A; Belliato M; Calvi M; Iacona I; Grugnetti G; Bonadeo E; Muzzi A; Cereda E
    Nutrition; 2020 Jun; 74():110835. PubMed ID: 32280058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional approach to patients with coronavirus: Our experience in a 914 COVID-19-bed hospital.
    Zanardi M; De Carli L; Ponta ML; Pezzana A
    Nutrition; 2021 Jun; 86():110965. PubMed ID: 32917467
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to "Nutritional approach to patients with coronavirus: our experience in 914 COVID-19-bed hospital".
    Caccialanza R; Lobascio F; Masi S; Crotti S; Cereda E
    Nutrition; 2021 Jun; 86():111203. PubMed ID: 33941426
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial.
    Majidi N; Rabbani F; Gholami S; Gholamalizadeh M; BourBour F; Rastgoo S; Hajipour A; Shadnoosh M; Akbari ME; Bahar B; Ashoori N; Alizadeh A; Samipoor F; Moslem A; Doaei S; Suzuki K
    Front Immunol; 2021; 12():717816. PubMed ID: 34975830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding: "The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial".
    Nakata T; Ariie T; Taito S
    J Transl Med; 2021 Jun; 19(1):282. PubMed ID: 34193209
    [No Abstract]   [Full Text] [Related]  

  • 8. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of omega‑3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID‑19: a randomized clinical trial.
    Safaei Ardestani SZ; Rahideh ST
    J Transl Med; 2022 Jan; 20(1):32. PubMed ID: 35033110
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Nutrition Risk and Its Association With Mortality Risk in Severely and Critically Ill COVID-19 Patients.
    Zhao X; Li Y; Ge Y; Shi Y; Lv P; Zhang J; Fu G; Zhou Y; Jiang K; Lin N; Bai T; Jin R; Wu Y; Yang X; Li X
    JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):32-42. PubMed ID: 32613660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory role and potential utility of various nutrients and dietary components in SARS-CoV-2 infection.
    Yaseen MO; Jamshaid H; Saif A; Hussain T
    Int J Vitam Nutr Res; 2022 Jan; 92(1):35-48. PubMed ID: 34100300
    [No Abstract]   [Full Text] [Related]  

  • 13. A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.
    Yu Y; Ge H; Wang X; Huang Z; Chen L; Han Y; Jiang D; Tao L; Zhou Q; Peng Z; Xiao X
    Ann Palliat Med; 2021 Jun; 10(6):6198-6207. PubMed ID: 34044555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Disease and Outcomes among Critically Ill Patients: The Case of Medical Nutritional Therapy.
    Karayiannis D; Kakavas S; Bouloubasi Z; Mastora Z
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition support practices for critically ill patients with severe acute respiratory syndrome coronavirus-2: A multicentre observational study in Singapore.
    Lew CCH; Ng PS; Wong KW; Puah SH; Lim CDQ; Kayambu G; Li AY; Toh CH; Venkatachalam J; Mukhopadhyay A
    Ann Acad Med Singap; 2022 Jun; 51(6):329-340. PubMed ID: 35786753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.
    Rabagliati R; Rodríguez N; Núñez C; Huete A; Bravo S; Garcia P
    Emerg Infect Dis; 2021 May; 27(5):1454-1456. PubMed ID: 33760726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible Mechanisms and Special Clinical Considerations of Curcumin Supplementation in Patients with COVID-19.
    Heidari Z; Mohammadi M; Sahebkar A
    Adv Exp Med Biol; 2021; 1308():127-136. PubMed ID: 33861442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious SARS-CoV-2 is rarely present in the nasopharynx samples collected from Swedish hospitalized critically ill COVID-19 patients.
    Ling J; Hickman RA; Frithiof R; Hultström M; Järhult JD; Lundkvist Å; Lipcsey M
    Ir J Med Sci; 2023 Feb; 192(1):227-229. PubMed ID: 35257294
    [No Abstract]   [Full Text] [Related]  

  • 19. Easy-to-prescribe nutrition support in the intensive care in the era of COVID-19.
    de Watteville A; Genton L; Barcelos GK; Pugin J; Pichard C; Heidegger CP
    Clin Nutr ESPEN; 2020 Oct; 39():74-78. PubMed ID: 32859332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper as a potential adjunct therapy for critically ill COVID-19 patients.
    Fooladi S; Matin S; Mahmoodpoor A
    Clin Nutr ESPEN; 2020 Dec; 40():90-91. PubMed ID: 33183578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.